ASIA Q1´20 – Latest Authorizations


Map with the frase Latest authorizations by the regulatory Agencies

Medichem´s DMFs for the Active Pharmaceutical Ingredient of Paroxetine and Rivaroxaban are filed and listed on the CDE website, China – Q1′ 20

Paroxetine is an antidepressant that belongs to the group of drugs called selective serotonin reuptake inhibitors (SSRIs).

Rivaroxaban is an anticoagulant medication or blood thinner used to treat and prevent blood clots.

Q4´19 Authorizations:

  • Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19
  • Medichem´s DMF for Quetiapine´s Active Pharmaceutical Ingredient is filed to the NMPA, China – Q4′ 19